United States Cyclophosphamide Market Report 2016

December 2016 | 96 pages | ID: UA30B64E6BCEN
QYResearch

Abstracts

Notes:

Sales, means the sales volume of Cyclophosphamide

Revenue, means the sales value of Cyclophosphamide

This report studies sales (consumption) of Cyclophosphamide in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering

• Pfizer
• Merck
• Allergan
• The Medicines Company
• Theravance Biopharma
• Basilea Pharmaceutica
• Sanofi

Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into

• Type I
• Type II
• Type III

Split by applications, this report focuses on sales, market share and growth rate of Cyclophosphamide in each application, can be divided into

• Application 1
• Application 2
• Application 3

Contents

United States Cyclophosphamide Market Report 2016

1 CYCLOPHOSPHAMIDE OVERVIEW

1.1 Product Overview and Scope of Cyclophosphamide
1.2 Classification of Cyclophosphamide
  1.2.1 Type I
  1.2.2 Type II
  1.2.3 Type III
1.3 Application of Cyclophosphamide
  1.3.1 Application
  1.3.2 Application
  1.3.3 Application
1.4 United States Market Size Sales (Value) and Revenue (Volume) of Cyclophosphamide (2011-2021)
  1.4.1 United States Cyclophosphamide Sales and Growth Rate (2011-2021)
  1.4.2 United States Cyclophosphamide Revenue and Growth Rate (2011-2021)

2 UNITED STATES CYCLOPHOSPHAMIDE COMPETITION BY MANUFACTURERS

2.1 United States Cyclophosphamide Sales and Market Share of Key Manufacturers (2015 and 2016)
2.2 United States Cyclophosphamide Revenue and Share by Manufactures (2015 and 2016)
2.3 United States Cyclophosphamide Average Price by Manufactures (2015 and 2016)
2.4 Cyclophosphamide Market Competitive Situation and Trends
  2.4.1 Cyclophosphamide Market Concentration Rate
  2.4.2 Cyclophosphamide Market Share of Top 3 and Top 5 Manufacturers
  2.4.3 Mergers & Acquisitions, Expansion

3 UNITED STATES CYCLOPHOSPHAMIDE SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (2011-2016)

3.1 United States Cyclophosphamide Sales and Market Share by Type (2011-2016)
3.2 United States Cyclophosphamide Revenue and Market Share by Type (2011-2016)
3.3 United States Cyclophosphamide Price by Type (2011-2016)
3.4 United States Cyclophosphamide Sales Growth Rate by Type (2011-2016)

4 UNITED STATES CYCLOPHOSPHAMIDE SALES (VOLUME) BY APPLICATION (2011-2016)

4.1 United States Cyclophosphamide Sales and Market Share by Application (2011-2016)
4.2 United States Cyclophosphamide Sales Growth Rate by Application (2011-2016)
4.3 Market Drivers and Opportunities

5 UNITED STATES CYCLOPHOSPHAMIDE MANUFACTURERS PROFILES/ANALYSIS

5.1 Pfizer
  5.1.1 Company Basic Information, Manufacturing Base and Competitors
  5.1.2 Cyclophosphamide Product Type, Application and Specification
    5.1.2.1 Type I
    5.1.2.2 Type II
  5.1.3 Pfizer Cyclophosphamide Sales, Revenue, Price and Gross Margin (2011-2016)
  5.1.4 Main Business/Business Overview
5.2 Merck
  5.2.2 Cyclophosphamide Product Type, Application and Specification
    5.2.2.1 Type I
    5.2.2.2 Type II
  5.2.3 Merck Cyclophosphamide Sales, Revenue, Price and Gross Margin (2011-2016)
  5.2.4 Main Business/Business Overview
5.3 Allergan
  5.3.2 Cyclophosphamide Product Type, Application and Specification
    5.3.2.1 Type I
    5.3.2.2 Type II
  5.3.3 Allergan Cyclophosphamide Sales, Revenue, Price and Gross Margin (2011-2016)
  5.3.4 Main Business/Business Overview
5.4 The Medicines Company
  5.4.2 Cyclophosphamide Product Type, Application and Specification
    5.4.2.1 Type I
    5.4.2.2 Type II
  5.4.3 The Medicines Company Cyclophosphamide Sales, Revenue, Price and Gross Margin (2011-2016)
  5.4.4 Main Business/Business Overview
5.5 Theravance Biopharma
  5.5.2 Cyclophosphamide Product Type, Application and Specification
    5.5.2.1 Type I
    5.5.2.2 Type II
  5.5.3 Theravance Biopharma Cyclophosphamide Sales, Revenue, Price and Gross Margin (2011-2016)
  5.5.4 Main Business/Business Overview
5.6 Basilea Pharmaceutica
  5.6.2 Cyclophosphamide Product Type, Application and Specification
    5.6.2.1 Type I
    5.6.2.2 Type II
  5.6.3 Basilea Pharmaceutica Cyclophosphamide Sales, Revenue, Price and Gross Margin (2011-2016)
  5.6.4 Main Business/Business Overview
5.7 Sanofi
  5.7.2 Cyclophosphamide Product Type, Application and Specification
    5.7.2.1 Type I
    5.7.2.2 Type II
  5.7.3 Sanofi Cyclophosphamide Sales, Revenue, Price and Gross Margin (2011-2016)
  5.7.4 Main Business/Business Overview

6 CYCLOPHOSPHAMIDE MANUFACTURING COST ANALYSIS

6.1 Cyclophosphamide Key Raw Materials Analysis
  6.1.1 Key Raw Materials
  6.1.2 Price Trend of Key Raw Materials
  6.1.3 Key Suppliers of Raw Materials
  6.1.4 Market Concentration Rate of Raw Materials
6.2 Proportion of Manufacturing Cost Structure
  6.2.1 Raw Materials
  6.2.2 Labor Cost
  6.2.3 Manufacturing Expenses
6.3 Manufacturing Process Analysis of Cyclophosphamide

7 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

7.1 Cyclophosphamide Industrial Chain Analysis
7.2 Upstream Raw Materials Sourcing
7.3 Raw Materials Sources of Cyclophosphamide Major Manufacturers in 2015
7.4 Downstream Buyers

8 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

8.1 Marketing Channel
  8.1.1 Direct Marketing
  8.1.2 Indirect Marketing
  8.1.3 Marketing Channel Development Trend
8.2 Market Positioning
  8.2.1 Pricing Strategy
  8.2.2 Brand Strategy
  8.2.3 Target Client
8.3 Distributors/Traders List

9 MARKET EFFECT FACTORS ANALYSIS

9.1 Technology Progress/Risk
  9.1.1 Substitutes Threat
  9.1.2 Technology Progress in Related Industry
9.2 Consumer Needs/Customer Preference Change
9.3 Economic/Political Environmental Change

10 UNITED STATES CYCLOPHOSPHAMIDE MARKET FORECAST (2016-2021)

10.1 United States Cyclophosphamide Sales, Revenue Forecast (2016-2021)
10.2 United States Cyclophosphamide Sales Forecast by Type (2016-2021)
10.3 United States Cyclophosphamide Sales Forecast by Application (2016-2021)
10.4 Cyclophosphamide Price Forecast (2016-2021)

11 RESEARCH FINDINGS AND CONCLUSION

12 APPENDIX

Disclosure Section
Research Methodology
Data Source
Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Cyclophosphamide
Table Classification of Cyclophosphamide
Figure United States Sales Market Share of Cyclophosphamide by Type in 2015
Table Application of Cyclophosphamide
Figure United States Sales Market Share of Cyclophosphamide by Application in 2015
Figure United States Cyclophosphamide Sales and Growth Rate (2011-2021)
Figure United States Cyclophosphamide Revenue and Growth Rate (2011-2021)
Table United States Cyclophosphamide Sales of Key Manufacturers (2015 and 2016)
Table United States Cyclophosphamide Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Cyclophosphamide Sales Share by Manufacturers
Figure 2016 Cyclophosphamide Sales Share by Manufacturers
Table United States Cyclophosphamide Revenue by Manufacturers (2015 and 2016)
Table United States Cyclophosphamide Revenue Share by Manufacturers (2015 and 2016)
Table 2015 United States Cyclophosphamide Revenue Share by Manufacturers
Table 2016 United States Cyclophosphamide Revenue Share by Manufacturers
Table United States Market Cyclophosphamide Average Price of Key Manufacturers (2015 and 2016)
Figure United States Market Cyclophosphamide Average Price of Key Manufacturers in 2015
Figure Cyclophosphamide Market Share of Top 3 Manufacturers
Figure Cyclophosphamide Market Share of Top 5 Manufacturers
Table United States Cyclophosphamide Sales by Type (2011-2016)
Table United States Cyclophosphamide Sales Share by Type (2011-2016)
Figure United States Cyclophosphamide Sales Market Share by Type in 2015
Table United States Cyclophosphamide Revenue and Market Share by Type (2011-2016)
Table United States Cyclophosphamide Revenue Share by Type (2011-2016)
Figure Revenue Market Share of Cyclophosphamide by Type (2011-2016)
Table United States Cyclophosphamide Price by Type (2011-2016)
Figure United States Cyclophosphamide Sales Growth Rate by Type (2011-2016)
Table United States Cyclophosphamide Sales by Application (2011-2016)
Table United States Cyclophosphamide Sales Market Share by Application (2011-2016)
Figure United States Cyclophosphamide Sales Market Share by Application in 2015
Table United States Cyclophosphamide Sales Growth Rate by Application (2011-2016)
Figure United States Cyclophosphamide Sales Growth Rate by Application (2011-2016)
Table Pfizer Basic Information List
Table Pfizer Cyclophosphamide Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Pfizer Cyclophosphamide Sales Market Share (2011-2016)
Table Merck Basic Information List
Table Merck Cyclophosphamide Sales, Revenue, Price and Gross Margin (2011-2016)
Table Merck Cyclophosphamide Sales Market Share (2011-2016)
Table Allergan Basic Information List
Table Allergan Cyclophosphamide Sales, Revenue, Price and Gross Margin (2011-2016)
Table Allergan Cyclophosphamide Sales Market Share (2011-2016)
Table The Medicines Company Basic Information List
Table The Medicines Company Cyclophosphamide Sales, Revenue, Price and Gross Margin (2011-2016)
Table The Medicines Company Cyclophosphamide Sales Market Share (2011-2016)
Table Theravance Biopharma Basic Information List
Table Theravance Biopharma Cyclophosphamide Sales, Revenue, Price and Gross Margin (2011-2016)
Table Theravance Biopharma Cyclophosphamide Sales Market Share (2011-2016)
Table Basilea Pharmaceutica Basic Information List
Table Basilea Pharmaceutica Cyclophosphamide Sales, Revenue, Price and Gross Margin (2011-2016)
Table Basilea Pharmaceutica Cyclophosphamide Sales Market Share (2011-2016)
Table Sanofi Basic Information List
Table Sanofi Cyclophosphamide Sales, Revenue, Price and Gross Margin (2011-2016)
Table Sanofi Cyclophosphamide Sales Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Cyclophosphamide
Figure Manufacturing Process Analysis of Cyclophosphamide
Figure Cyclophosphamide Industrial Chain Analysis
Table Raw Materials Sources of Cyclophosphamide Major Manufacturers in 2015
Table Major Buyers of Cyclophosphamide
Table Distributors/Traders List
Figure United States Cyclophosphamide Production and Growth Rate Forecast (2016-2021)
Figure United States Cyclophosphamide Revenue and Growth Rate Forecast (2016-2021)
Table United States Cyclophosphamide Production Forecast by Type (2016-2021)
Table United States Cyclophosphamide Consumption Forecast by Application (2016-2021)